Xuanrong Sun

3.1k citations
57 papers · 2.7k indexed · 1 hit paper · h-index 22
Topics
Nanoparticle-Based Drug Delivery (19 papers)RNA Interference and Gene Delivery (12 papers)Nanoplatforms for cancer theranostics (12 papers)

In The Last Decade

Xuanrong Sun

53 papers receiving 2.7k citations

Hit Papers

In Vivo and in Situ Tracking Cancer Chemotherapy by Highl...20142026201820222014100200300400

Peers

Xuanrong Sun
Comparison fields: 5 of 95
  • Biomedical Engineering 1.3k
  • Biomaterials 1.2k
  • Molecular Biology 1.1k
  • Materials Chemistry 600
  • Organic Chemistry 372
Replace Si‐Yong Qin with:
Si‐Yong Qin China
Chunhua Ren China
Xiangrui Liu China
Qiming Kan China
Tanyel Kiziltepe United States
Ying Piao China
Xiao‐Jiao Du China
Xiaopin Duan China
Dong‐Eun Lee South Korea
Meihua Sui China
Xuanrong Sun relative to Si‐Yong Qin China Si‐Yong Qin's profile →
Citations per field
00.5×1.5×
Si‐Yong Qin · 1×
Citations per year

Countries citing papers authored by Xuanrong Sun

Since Specialization
Citations

This map shows the geographic impact of Xuanrong Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuanrong Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuanrong Sun more than expected).

Fields of papers citing papers by Xuanrong Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuanrong Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuanrong Sun. The network helps show where Xuanrong Sun may publish in the future.

Co-authorship network of co-authors of Xuanrong Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Xuanrong Sun. A scholar is included among the top collaborators of Xuanrong Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuanrong Sun. Xuanrong Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 0
4 1
5 3
6 7
7 13
8 8
9 25
10 33
11 15
12 10
13 6
14 6
15 3
16 37
17 4
18 129
19 6
20 55

About Xuanrong Sun

Xuanrong Sun is a scholar working on Biomaterials, Toxicology and Pharmaceutical Science, having authored 57 papers that have together received 2.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (19 papers), RNA Interference and Gene Delivery (12 papers) and Nanoplatforms for cancer theranostics (12 papers). The work is most often cited by research in Biomaterials (1.2k citations), Biomedical Engineering (1.3k citations) and Pharmaceutical Science (111 citations). Xuanrong Sun has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Youqing Shen, Jianbin Tang, Jianbin Tang, Zhiqian Guo, Xumeng Wu, Weihong Zhu, He Tian, Meihua Sui, Tony D. James and Zhuxian Zhou. Their work appears in journals such as Journal of the American Chemical Society, Advanced Materials and ACS Nano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026